SOL Global Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
SOL Global Investments Corp. announced a normal course issuer bid (NCIB) to repurchase up to 2,737,805 common shares, about 5% of its outstanding shares, due to their belief that the market price does not reflect the company's underlying value. The NCIB is set to commence on March 31, 2021. The Company plans to appoint Clarus Securities as its broker for the buyback. This initiative is part of SOL Global's strategy to enhance shareholder value, with the 2020 financial results expected to be released on March 29, 2021.
- Announcement of NCIB to repurchase 2,737,805 shares, enhancing shareholder value.
- Management believes shares are significantly undervalued, indicating future growth potential.
- Market price undervaluation may indicate underlying investor concerns or market sentiment.
- Dependency on the successful execution of portfolio companies' business plans poses risk.
SOL Global Investments Corp. (“SOL Global” or the "Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) announces its intention to commence a normal course issuer bid (“NCIB”), under which the Company may purchase up to 2,737,805 of the Company’s common shares, representing approximately
The NCIB is expected to commence on March 31, 2021 and terminate on March 31, 2022. All Common Shares purchased under the NCIB will be purchased on the open market through the facilities of the Canadian Securities Exchange (the “CSE”). All purchases made under the NCIB will be at the prevailing CSE market price for the Common Shares at the time of purchase. Common Shares acquired by the Company under the NCIB are being purchased for cancellation. The Company intends to appoint Clarus Securities Inc. as its broker to conduct the NCIB on its behalf.
“We believe that SOL Global is trading significantly below its net asset value; therefore, one of the best stocks we can buy is our own,” said Andy DeFrancesco, Chairman and CEO of SOL Global.
Annual 2020 Financial Statements
The Company is anticipating releasing its 2020 audited financial results on Monday, March 29, 2021 after the close of market trading.
About SOL Global Investments Corp.:
SOL Global is a diversified investment and private equity holding company engaged in the small and mid-cap sectors. The Company’s investment partnerships range from minority positions to large strategic holdings with active advisory mandates. The Company’s seven primary business segments include Retail, Agriculture, QSR & Hospitality, Media Technology & Gaming, and New Age Wellness.
Non-IFRS Financial Measures
This press release includes references to net asset value, which is a financial measure that does not have a standardized meaning prescribed by IFRS. Net asset value is calculated as the value of total assets less the value of total liabilities at a specific date. The Company believes this non-IFRS measure does not only provide management with comparable financial data for internal financial analysis but also provides meaningful supplemental information to investors. In particular, management believes this financial measure can provide information useful to its shareholders in understanding the performance of the Company and may assist in the evaluation of its business relative to that of its peers. Investors are cautioned that this non-IFRS measure should not be construed as an alternative to the measurements calculated in accordance with IFRS as, given the non-standardized meaning, it may not be comparable to similar measures presented by other issuers.
Cautionary Statement Regarding Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained in this press release includes, without limitation, the commencement of the NCIB and timing of the release of the 2020 annual financial statements of the Company.
Forward-looking information is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.
By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation, changes in economic conditions or financial markets and disruptions to the Company’s business and operations due to the COVID-19 pandemic including any resurgence in COVID-19 cases.
Other risk factors include: the risks resulting from investing in the US marijuana industry, which may be legal under certain state and local laws but is currently illegal under U.S. federal law; the risks of investing in securities of private companies which may limit the Company’s ability to sell or otherwise liquidate those securities and realize value; the ability of the Company’s portfolio companies to successfully execute on their business plans as contemplated or at all; reliance on management; the ability of the Company to service its debt; the Company’s ability to obtain additional financing from time to time to pursue its business objectives; competition; litigation; inconsistent public opinion and perception regarding the medical-use and adult-use marijuana industry; and regulatory or political change. Additional risk factors can also be found in the Company's current MD&A, which has been filed on SEDAR and can be accessed at www.sedar.com. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005624/en/
FAQ
What is the purpose of SOL Global's normal course issuer bid (NCIB)?
When does the NCIB for SOL Global start and end?
How many shares will SOL Global buy back under the NCIB?
Who will conduct the buyback for SOL Global?
When will SOL Global announce its 2020 financial results?
